Aristotle University of Thessaloniki   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Thessaloniki Greece (1925)

Organization Overview

First Clinical Trial
1999
NCT03031834
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

1st Cardiology Department, University General Hospital AHEPA, Thessaloniki | 1st Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece | 1st Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki | 1st ICU, G. papanikolaou Hospital, Thessaloniki, Greece | 3rd University Cardiology Clinic of Ippokrateion Hospital, Thessaloniki, Greece | AHEPA Hospital Aristotle University Of Thessaloniki | AHEPA hospital of Thessaloniki, Greece | AHEPA Thessaloniki University General Hospital. Greece | AHEPA University Hospital | AHEPA University Hospital/ Aristotle University of Thessaloniki | Aristotle's University of Thessaloniki | Aristotle Univeristy | Aristotle University | Aristotle University Of Thessaloniki | Aristotle University of Thessaloniki, General Hospital of Papanikolaou | Aristotle University of Thessaloniki, Greece | Aristotle University of Thessaloniki Medical School | Aristotle University of Thessaloniki, Medical School | Aristotle University of Thessaloniki, School of engineering, Faculty of Chemical Engineering, Division of technology laboratory of food and process engineering, | Aristotle University of Thessaloniki School of Medicine | Aristotle University Of Thessaloniki, School of Medicine | Associate Prof., Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki | AXEPA University of Thessaloniki, 1st Department of Propedeutic Surgery, Thessaloniki, Greece | Clinical Research Unit, School of Medicine, Aristotle University of Thessaloniki | Department of Biochemistry, Ippokration Hospital, Thessaloniki, Greece | Department of Medicine, Aristotle University of Thessaloniki | Department of Nutrition and Dietetics, AHEPA University Hospital, Thessaloniki | Department of Pathology, Ippokration Hospital, Thessaloniki, Greece | Department of Physical Education and Sports Sciences Aristotle University of Thessaloniki, Greece | Department of Physiology and Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki (A.U.Th), Thessaloniki, PC 54124, Greece | Department of Radiology, Ippokration Hospital, Thessaloniki, Greece | Dept. of Periodontology and Implant Biology, School of Dentistry, Aristotle University of Thessaloniki | Divison of Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Greece | General Hospital Of Thessaloniki Ippokratio | Georgia Tsaousi | Glaucoma Unit, A University Department of Ophthalmology, AHEPA Hospital, Thessaloniki, Greece | Glaucoma Unit, A University Dept of Ophthalmology, AHEPA Hospital | Hippocration General Hospital | Hippokrateion hospital of Thessaloniki | Hippokratio General Hospital, Thessaloniki, Greece | Hippokration hospital of Thessaloniki, Greece | Hippokration hospital, Thessaloniki | Institute for the Study of Urological Diseases, Greece | Institute for the Study of Urological Diseases, Thessaloniki, Greece | Ippokration Hospital, Thessaloniki | Papanikolaou hospital of Thessaloniki, Greece | Papanikolaou hospital, Thessaloniki | Retired, Dept. of Preventive Dentistry, Periodontology and Implant Biology, School of Dentistry, Aristotle University of Thessaloniki | School of Medicine, Aristotle University of Thessaloniki | School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki (A.U.Th.), Greece | Second Medical Clinic, Medical School, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece | Theageneio Anticancer Hospital of Thessaloniki | Theagenio Cancer Hospital | Theagenion Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology | Theagenion Hospital, Thessaloniki, Greece | Unit for Human Reproduction, 1st Dept. of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki | Unit of Human Reproduction, 1st Dept of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki Thessaloniki, Greece | Unit of Pediatric Endocrinology, Diabetes and Metabolism-4th Department of Pediatrics, Medical School of Aristotle University of Thessaloniki | Unit of Pediatric Endocrinology, Diabetes and Metabolism - 4th Department of Pediatrics, Medical School of Aristotle University of Thessaloniki, 56403 Thessaloniki, Greece | University General Hospital of Thessaloniki AHEPA, 1st University Pathology Clinic | University Hospital AHEPA,Thessaloniki,Greece | University Hospital of Thessaloniki Hippokrateion | University of Thessaloniki

Active Ingredients

Drugs in Phase 4 Trials (57)

acetaminophen (tylenol) (2 trials)

alendronic acid (fosamax) (2 trials)

amlodipine (norvasc) (1 trial)

atorvastatin (lipitor) (4 trials)

bimatoprost (lumigan) (2 trials)

brimonidine (alphagan) (2 trials)

brinzolamide (azopt) (1 trial)

calcium (1 trial)

cangrelor (kengreal) (1 trial)

cannabidiol (Epidiolex) (1 trial)

cetrorelix (cetrotide) (1 trial)

clopidogrel (plavix) (1 trial)

corifollitropin alfa (1 trial)

denosumab (prolia) (3 trials)

dexmedetomidine (precedex) (2 trials)

dorzolamide (trusopt) (3 trials)

droperidol (innovar) (1 trial)

empagliflozin (jardiance) (1 trial)

enoxaparin (lovenox) (1 trial)

eplerenone (inspra) (1 trial)

ferric carboxymaltose (Injectafer) (1 trial)

follitropin alfa (1 trial)

homotaurine (1 trial)

insulin aspart (novolog) (2 trials)

irbesartan (avapro) (1 trial)

ketamine (ketalar) (1 trial)

latanoprost (xalatan) (7 trials)

levosimendan (1 trial)

lidocaine (xylocaine) (1 trial)

magnesium (1 trial)

magnesium sulfate (Tis-U-Sol) (2 trials)

mannitol (1 trial)

morphine (1 trial)

moxonidine (1 trial)

nebivolol (bystolic) (2 trials)

orlistat (xenical) (1 trial)

parecoxib (1 trial)

phenylephrine (Prefrin) (2 trials)

probiotic (1 trial)

propofol (diprivan) (2 trials)

quinapril (accupril) (1 trial)

ramipril (altace) (1 trial)

ropivacaine (naropin) (3 trials)

selenomethionine se-75 (1 trial)

sevoflurane (ultane) (1 trial)

sibutramine (meridia) (2 trials)

sitagliptin (januvia) (4 trials)

sodium chloride (2 trials)

tafluprost (zioptan) (3 trials)

telmisartan (micardis) (1 trial)

thiopental (pentothal) (2 trials)

ticagrelor (brilinta) (1 trial)

timolol (blocadren) (12 trials)

tramadol (Ultram) (2 trials)

travoprost (travatan) (4 trials)

tropicamide (mydriacyl) (2 trials)

valsartan (diovan) (1 trial)

Drugs in Phase 3 Trials (13)

allogeneic adipose derived mesenchymal stem cell (1 trial)

amiodarone (cordarone) (1 trial)

clarithromycin (biaxin) (1 trial)

colchicine (colbenemid) (1 trial)

flecainide (tambocor) (2 trials)

glucose monohydrate (1 trial)

glyceryl trinitrate (1 trial)

metoprolol (lopressor) (1 trial)

nivaldipine (1 trial)

platelet rich plasma (3 trials)

ranolazine (ranexa) (1 trial)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

testosterone (delatestryl) (1 trial)

Drugs in Phase 2 Trials (30)

anakinra (kineret) (1 trial)

bone marrow derived mesenchymal stem cells (2 trials)

bortezomib (velcade) (1 trial)

capecitabine (xeloda) (1 trial)

chloroquine (1 trial)

cisplatin (platinol) (1 trial)

collagen (2 trials)

docetaxel (taxotere) (1 trial)

doxorubicin (Doxil) (1 trial)

fenofibrate (fenoglide) (1 trial)

ferrous sulfate (1 trial)

fluorouracil (efudex) (1 trial)

human fibrin (2 trials)

irinotecan (Camptosar) (1 trial)

lactose (1 trial)

lenalidomide (revlimid) (1 trial)

leucovorin (1 trial)

mesalamine (rowasa) (1 trial)

olmesartan (benicar) (2 trials)

oxaliplatin (eloxatin) (1 trial)

platelet lysate (1 trial)

red wine (1 trial)

rituximab (rituxan) (1 trial)

spironolactone (aldactone) (1 trial)

sulfamethoxazole (gantanol) (1 trial)

trimethoprim (1 trial)

triptorelin (Trelstar) (1 trial)

urea (2 trials)

vancomycin (Vancocin) (1 trial)

vitamin e (1 trial)

Drugs in Phase 1 Trials (2)

methylsulfonylmethane (1 trial)

prednisone (meticorten) (1 trial)

Drugs in Other Trials (21)

Agropyron repens (1 trial)

chlorthalidone (Hygroton) (1 trial)

desflurane (suprane) (1 trial)

egg white (1 trial)

Insulin, bovine (1 trial)

insulin human (humulin) (1 trial)

maltodextrin (2 trials)

metaiodobenzylguanidine (1 trial)

metformin (glucophage) (1 trial)

methylcobalamin (1 trial)

pomegranate extract (1 trial)

procyanidin (2 trials)

rimonabant (1 trial)

saffron (1 trial)

strontium ranelate (1 trial)

tadalafil (cialis) (1 trial)

teriparatide (1 trial)

varenicline (chantix) (1 trial)

vitamin k2 (1 trial)

whey protein (2 trials)

zoledronic acid (zometa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 3)

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Arterial Occlusive Diseases (Phase 4)

Atherosclerosis (Phase 4)

Atrial Fibrillation (Phase 3)

Brain Edema (Phase 4)

Brain Neoplasms (Phase 4)

Cardiomyopathies (Phase 3)

Chronic Periodontitis (Phase 2)

Communicable Diseases (Phase 2)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Coronavirus Infections (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Nephropathies (Phase 4)

Diabetic Neuropathies (Phase 4)

Erectile Dysfunction (Phase 3)

Exfoliation Syndrome (Phase 3)

Fatty Liver (Phase 2)

Fever (Phase 4)

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 4)

Hashimoto Disease (Phase 4)

Heart Failure (Phase 3)

Hypercholesterolemia (Phase 2)

Hypertension (Phase 4)

Hypoxia (Phase 4)

Infections (Phase 2)

Infertility (Phase 4)

Inflammation (Phase 4)

Insulin Resistance (Phase 4)

Ischemia (Phase 2)

Kidney Diseases (Phase 4)

Liver Diseases (Phase 2)

Multiple Myeloma (Phase 4)

Myocardial Ischemia (Phase 4)

Neonatal Sepsis (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Neuritis (Phase 1)

Non-alcoholic Fatty Liver Disease (Phase 2)

Obesity (Phase 4)

Ocular Hypertension (Phase 4)

Osteoarthritis (Phase 1)

Overweight (Phase 4)

Pain, Postoperative (Phase 4)

Periodontitis (Phase 2)

Peripheral Nervous System Diseases (Phase 4)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Polycystic Ovary Syndrome (Phase 4)

Postoperative Complications (Phase 4)

Postoperative Nausea and Vomiting (Phase 4)

Premature Birth (Phase 4)

Recurrence (Phase 3)

Respiratory Insufficiency (Phase 2)

Respiratory Tract Infections (Phase 2)

Retinal Diseases (Phase 4)

Retinopathy of Prematurity (Phase 4)

Sepsis (Phase 3)

Severe Acute Respiratory Syndrome (Phase 2)

Spinal Diseases (Phase 4)

Spinal Stenosis (Phase 4)

ST Elevation Myocardial Infarction (Phase 4)

Stomach Neoplasms (Phase 2)

Stroke (Phase 2)

Syndrome (Phase 4)

Tennis Elbow (Phase 2)

Thyroiditis (Phase 4)

Thyroiditis, Autoimmune (Phase 4)

Toxemia (Phase 3)

Vascular Diseases (Phase 4)

Vestibular Neuronitis (Phase 1)

Virus Diseases (Phase 2)

Vomiting (Phase 4)

Waldenstrom Macroglobulinemia (Phase 2)

Weight Loss (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 104
  • # of Trial APIs: 123